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Before beginning the review of this book, we had no par-
ticular opinion about the role of low carbohydrate diets in
diabetes. In order to write a fair and unbiased review, we
have done a rather extensive search on the subject. One of
the most disturbing findings of our search is the amount
of hostility towards low carbohydrate diets that is on the
web and in the scientific literature. We found several sites
that present no scientific arguments but are, rather, full of
ad hominem attacks. This was particularly disturbing in
that we are in the midst of a growing epidemic of obesity
and diabetes with very alarming figures and projections
from all over the world. Any intervention that has the
potential for helping curb this dangerous epidemic which
claims thousands of lives every day should be looked at
with a great deal of objectivity.
The low carbohydrate approach, in fact, is not new and
was used in England more than a century ago, made pop-
ular by William Harvey [1], an ENT surgeon. He pre-
scribed a low carbohydrate diet for William Banting, an
obese carpenter who had been having a great difficulty
losing weight. Banting was able to lose weight and as a
service, he published in 1863 a small booklet entitled Let-
ter on Corpulence Addressed to the Public [2], the first book
to be published on obesity and one which popularized
low carbohydrate diets. He has been called "Father of low
carbohydrate diets" and was honored by his name being
included in the dictionary as the verb "to bant" meaning
"to diet". The low carbohydrate diet also been called a
"Harvey-Banting diet" after the names of these pioneer.
Since then, it has been in and out of fashion with different
versions and names but with the same underlying con-
cept, most recently popularized by the late Dr. Robert C.
Atkins.
The Atkins Diabetes Revolution [3] plan is similar to the
Atkins weight loss strategy: four levels of carbohydrate
restriction are instituted. The induction phase restricts
dieters to 20 g of carbohydrate. On the weight loss plan,
this is recommended for about 2 weeks. In diabetes this is
maintained until glycemic control is attained. In the latter
stages, carbohydrates are added as long as weight loss or
stability is maintained. For diabetes, carbohydrates are
only reintroduced if glycemic control is acceptable. In the
later phases, the Atkins Diabetes plan adds a Glycemic
Ranking (AGR), derived from the glycemic index, glyc-
emic load and net carbs. Preference is given to whole fruits
and berries and juices and dried fruits are low on the list.
As in weight loss, exercise is "mandatory."
The Atkins Diabetes Revolution book is an attempt by the
authors to present the low carbohydrate diet as a preven-
tive and treatment strategy for patients with type 2 diabe-
tes and those with the metabolic syndrome, who are at
high risk for developing diabetes and cardiovascular dis-
ease. In doing so, the book, which is very well written, and
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which clearly presents illustrative cases, explains very
complex metabolic concept in a very easy to read and
understandable format. The first nine chapters explain the
different concepts involved in glucose and lipid metabo-
lism and the interplay of the various cardiovascular risk
factors that culminate in cardiovascular disease the
number one killer of Americans today. Definitions of met-
abolic syndrome, pre-diabetes, body mass index, waist to
hip ratio, central obesity and their relationship to diabe-
tes, heart attacks and strokes, are eloquently presented
with a great deal of accuracy yet in a simple format. Most
impressive were the case presentations, especially that of
reactive hypoglycemia and carbohydrate craving. This
response is associated with hyperinsulinemia in the pre-
diabetic phase and sometimes puzzles clinicians unless
they know to look for it.
The second section of the book is devoted to an in-depth
discussion of the various macro and micronutrients and
their role in diabetes and obesity. Concepts such as the
glycemic index and glycemic load are very well illustrated.
The last section consists of meal plans and menus of low
carbohydrate diet that the book is advocating.
The concept of low carbohydrate diet and glycemic con-
trol certainly has a pathophysiological merit. First, dietary
carbohydrates are the principal source for the initial rise of
glucose in the diabetic populations, who generally have a
defect in the first phase insulin secretion that is responsi-
ble for handling the glucose load [4]. There is mounting
evidence that postprandial hyperglycemia is in itself a risk
factor for cardiovascular disease in the diabetic patients
[5]. This evidence comes from large, well-conducted, ran-
domized controlled trials [5,6]. Furthermore, control of
postprandial hyperglycemia has been shown to provide
cardiovascular benefits, and contribute to the overall
decrease of hemoglobin A1c, something that has been
clearly shown to reduce microvascular disease in both
type 1 and type 2 diabetes [7,8]. Second, the initial blood
glucose rise associated with high carbohydrate load, in the
presence of absolute/relative insulin deficiency leads to
significant rise in triglycerides and free fatty acids which
perpetuate the cycle of insulin resistance [9,10]. So, from
a metabolic stand point, low carbohydrate diet makes
physiologic sense. However, in the science and practice of
medicine, not everything that makes sense turns out to
work the way it is supposed to. In looking at the low car-
bohydrate diet, we must examine the evidence from the
studies that were conducted using such diets keeping in
mind that weight loss by itself, is beneficial in terms of
improving insulin sensitivity and correcting the abnor-
malities associated with the metabolic syndrome and
insulin resistance [9,10]. Also, weight loss has much
greater effect on the prevention of type 2 diabetes in pre-
diabetic patients than pharmacological interventions [9].
This fact was well illustrated in the Diabetes Prevention
Program, a large multicenter trial sponsored by the
National Institute of Health, where pre-diabetic patients
on diet and exercise program had a 58% reduction in the
development of diabetes, compared to only 34% reduc-
tion with the use of metformin [11]. This landmark study
had a population where women and minorities were very
well represented [11]. The fact that weight loss was associ-
ated with reduction of type 2 diabetes in high risk popu-
lations was illustrated in several other studies including
examples from Finland and from China, making it evi-
dent that weight loss works for a variety of ethnic popula-
tions [12-15].
In two recent randomized controlled trials published in
the New England Journal of Medicine [16,17], the effects
of low carbohydrate and low fat diets were compared in
obese and diabetic patients. Both of these studies showed
a substantial decrease of triglycerides in patients on low
carbohydrate diet with simultaneous increase in high-
density lipoprotein (HDL) over 6 month to 1 year period.
The studies did not show a change in the low-density lipo-
protein (LDL) values in the low carbohydrate group com-
pared to their baseline, while those on traditional low fat
diet had a reduction in LDL levels. Patients on low carbo-
hydrate diet, however, had substantially significant
weight loss, almost double that achieved with the tradi-
tional diet, in the first 3–6 months. At one year, there was
no significant difference in weight loss between the two
groups [16-18]. Although participants on the low carbo-
hydrate diet initially tended to have higher rate of side
effects such as nausea, muscle cramps and constipation,
compliance with diet was similar in both groups. In fact,
more participants adhered to the low carbohydrate diet.
Although weight loss was similar after one year between
groups, the effects on atherogenic dyslipidemia and glyc-
emic control were still more favorable with a low-carbo-
hydrate diet after adjustment for differences in weight
loss.
Despite the evidence from these randomized controlled
trials, published in the prestigious New England Journal
of Medicine, there is a significant amount of reluctance in
the scientific community to acknowledge the beneficial
effects of low carbohydrate diets. These studies, in fact,
provide a striking example of this resistance. A commen-
tary in the same issue of the New England Journal of Med-
icine [20] states that "In both studies, the reduction in
serum triglyceride levels in subjects randomly assigned to
the low-carbohydrate diet might have been anticipated as
a result of their greater weight loss, although it is true that
reduced carbohydrate intake is generally associated with
reduced triglyceride levels" [20]. In this statement, despite
the fact that low carbohydrate diet is known to reduce
serum triglyceride, the authors suggest otherwise. InNutrition & Metabolism 2004, 1:14 http://www.nutritionandmetabolism.com/content/1/1/14
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another statement, the authors of the commentary state
that "the rise in HDL cholesterol in the subjects following
the low-carbohydrate diet (a change observed only by Fos-
ter et al.) may reflect a change in HDL subfractions that
occurs with increased intake of saturated fats, and this
change has not been shown to be beneficial. Thus, caution
is urged about over-interpretation of this observation as a
beneficial result of a low-carbohydrate, high-fat diet" [20].
Again this statement illustrates the difficulty in acknowl-
edging what a randomized controlled trial has shown. The
authors suggest, without any evidence that the rise in HDL
cholesterol might have been in the non-beneficial HDL
subfraction. In other words, when low carbohydrate diet
is shown to decrease triglycerides, a suggestion is made
that it might be just secondary to weight loss and when
this diet increases HDL, it is also suggested that it could be
the non-beneficial HDL. Now, let us examine the evidence
provided by the one year follow-up study on the same
group of patients where the investigators conclude that
"Although weight loss was similar between groups, the
effects on atherogenic dyslipidemia and glycemic control
were still more favorable with a low-carbohydrate diet
after adjustment for differences in weight loss" [18]. This
indicates that the statements made in the commentary
[20], in an attempt to dismiss or downplay the beneficial
effects of low carbohydrate diet were simply wrong. Fur-
thermore, the statement made in the commentary regard-
ing the HDL cholesterol, not only lacks objective
evidence, but also contradicts the current findings that
lowering insulin level by controlled carbohydrates shift
HDL production to a much more desirable, lighter
HDL2subfractions [21,22].
On the other hand, the American Diabetes Association,
despite recommending the traditional low fat diet, has
recently reduced the recommended carbohydrate con-
tents in the diet, perhaps reflecting a trend towards a
reduced carbohydrate diet to follow [19].
Returning to the Atkins book, despite the fact that the
book is very well referenced, certain statements such as
"high carbohydrate diet leads to diabetes" are not well
substantiated, unless of course such a diet leads to weight
gain, which it may. Furthermore, the book does not
devote a sufficient amount of space discussing the side
effects associated with dieting in general and low carbohy-
drate diet in particular. This is of concern, since it leaves
the reader with the impression that the low carbohydrate
diet or dieting, in general, has no negative consequences.
Nonetheless, the amount of information the book pro-
vides in a simple, yet accurate format will benefit patients
with diabetes and their families as well as those who are
at risk for developing diabetes and the metabolic syn-
drome. If, after reading this book, the reader is able to
identify that he or she is at risk for diabetes and the meta-
bolic syndrome and takes action that could potentially
save his or her life the book will be a valuable contribu-
tion. Atkins Diabetes Revolution has a list price of $25.95
and is available at Amazon.com and presumably other
sites for half that price. Possibly, a shorter and still more
affordable version of the book would be helpful for dia-
betic patients, their families and for the general reader, to
help identify their risk for the disease.
As clinicians, we would not be comfortable recommend-
ing any diet without first hand experience. The Atkins Dia-
betes Revolution, however, is sufficiently convincing to
make us believe that some form of low carbohydrate inter-
vention is worth investigating and should be considered
by practitioners. The highly negative un-scientific
response of critics, if anything, encourages us in this direc-
tion.
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